Orion biotechnology log in

Orion Biotechnology: Home

Home – Orion Biotechnology

Orion Biotechnology is discovering and developing G Protein-Coupled Receptor (GPCR) targeted therapeutics for the treatment of cancer and other serious …

About – Orion Biotechnology

The company is advancing a diversified pipeline of potential first-in-class/best-in-class antagonist and agonist therapies against high-value GPCR targets in …

ORION BIOTECH OPPORTUNITIES

Orion Biotech Opportunities Corp. … industry, sector, or geographical location, we intend to focus on the biotechnology and life sciences industries.

Orion Biotechnology | LinkedIn

Jun 5, 2021 — Orion is a clinical stage company leveraging a proprietary technology platform to develop next generation therapeutics for effectively …

Orion Biotechnology – Crunchbase Company Profile & Funding

Orion Biotechnology is developing a pipeline of best-in-class biologic therapeutics based on Chemokine Analogue inhibitors, for the treatment of a broad …

Orion Biotechnology is a clinical stage biotechnology company that develops novel medical treatments.

Orion Biotechnology Company Profile: Valuation & Investors

Orion Biotechnology Company Profile: Valuation & Investors | PitchBook

The company leverages its proprietary drug discovery platform to advance in a promising new class of highly potent drugs to unlock a set of high-value GPCR …

Information on valuation, funding, cap tables, investors, and executives for Orion Biotechnology. Use the PitchBook Platform to explore the full profile.

Orion Biotechnology Switzerland – Swiss Biotech Association

Orion Biotechnology Switzerland – Swiss Biotech

Orion is the only company with a novel approach to drug peptide and protein GPCRs. Our platform offers one of the fastest drug discovery solutions in industry …

Orion

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being.

Orion Biotechnology and Peptilogics Enter Strategic

Jul 12, 2022 — logo. Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable AI-Driven Drug Discovery Against Undrugged GPCR …

Ottawa, Canada & Pittsburgh, USA, July 12, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery company targeting previously…

ORION BIOTECHNOLOGY PRESENTING NEW DATA ON ITS …

ORION BIOTECHNOLOGY PRESENTING NEW DATA ON ITS LATEST

May 10, 2022 — logo · ORION BIOTECHNOLOGY PRESENTING NEW DATA ON ITS LATEST BEST-IN-CLASS GPCR DRUG CANDIDATE.

Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic…